Cardiac manifestations of sarcoidosis
DOI:
https://doi.org/10.12775/JEHS.2022.12.07.060Keywords
sarcoidosis, cardiac sarcoidosis, cardiac magnetic resonance, cardiac positron emission tomography, heart failureAbstract
Introduction and purpose: Sarcoidosis is a chronic, multi-system inflammatory disorder of unknown etiology. Due to the varied clinical picture of patients, the diagnosis of the disease is complicated, especially when the heart is affected.The aim of this article is to review the available diagnostic tools used for the diagnosis, evaluation and monitoring of patients with suspected cardiac sarcoidosis.
Description of the state of knowledge: Sarcoidosis may affect any organ, but in particular lungs, skin, lymph nodes, eyes, liver and spleen. The most common manifestations are persistent cough, skin changes, visual disturbances, peripheral lymphadenopathy, fatigue and incidental abnormal chest radiograph. Cardiac sarcoidosis, occurring in about 5% of patients, is clinically significant with a wide range of symptoms including conduction abnormalities, ventricular arrhythmias, heart failure and sudden death. The diagnosis of cardiac sarcoidosis is challenging and often requires a combined approach using clinical data and advanced imaging. Invasive and non-invasive diagnostic tests are helpful in assessing the severity of heart involvement, with non-invasive tests becoming increasingly important, due to low sensitivity (30%) and high complication rate of endomyocardial biopsy for the diagnosis of cardiac sarcoidosis.
Summary: Sarcoidosis significantly increases the mortality of patients and furthermore causes impaired quality of life and disability. Attempts to accurately assess the development of disease provide a more comprehensive and personalized care for patients. Especially cardiac sarcoidosis, as a potentially life-threatening localization, requires early diagnosis and appropriate treatment.
References
Polverino F, Balestro E, Spagnolo P. Clinical Presentations, Pathogenesis, and Therapy of Sarcoidosis: State of the Art. J Clin Med. 2020;9(8):2363. Published 2020 Jul 24. doi:10.3390/jcm9082363
Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Müller-Quernheim J. Sarcoidosis. Lancet. 2014;383(9923):1155-1167. doi:10.1016/S0140-6736(13)60680-7
Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt MS, Blankstein R. Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther. 2016;6(1):50-63. doi:10.3978/j.issn.2223-3652.2015.12.13
Fernandez-Faith E, McDonnell J. Cutaneous sarcoidosis: differential diagnosis. Clin Dermatol. 2007;25(3):276-287. doi:10.1016/j.clindermatol.2007.03.004
Birnie DH, Nery PB, Ha AC, Beanlands RS. Cardiac Sarcoidosis. J Am Coll Cardiol. 2016;68(4):411-421. doi:10.1016/j.jacc.2016.03.605
Caforio ALP, Adler Y, Agostini C, et al. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J. 2017;38(35):2649-2662. doi:10.1093/eurheartj/ehx321
Hyodo E, Hozumi T, Takemoto Y, et al. Early detection of cardiac involvement in patients with sarcoidosis by a non-invasive method with ultrasonic tissue characterisation. Heart. 2004;90(11):1275-1280. doi:10.1136/hrt.2003.027763
Markatis E, Afthinos A, Antonakis E, Papanikolaou IC. Cardiac sarcoidosis: diagnosis and management. Rev Cardiovasc Med. 2020;21(3):321-338. doi:10.31083/j.rcm.2020.03.102
Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007 Nov 22;357(21):2153-65. doi: 10.1056/NEJMra071714. PMID: 18032765.
Kraaijvanger R, Janssen Bonás M, Vorselaars ADM, Veltkamp M. Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects. Front Immunol. 2020;11:1443. Published 2020 Jul 14. doi:10.3389/fimmu.2020.01443
Saric P, Young KA, Rodriguez-Porcel M, Chareonthaitawee P. PET Imaging in Cardiac Sarcoidosis: A Narrative Review with Focus on Novel PET Tracers. Pharmaceuticals (Basel). 2021;14(12):1286. Published 2021 Dec 9. doi:10.3390/ph14121286
Greulich S, Kitterer D, Latus J, et al. Comprehensive Cardiovascular Magnetic Resonance Assessment in Patients With Sarcoidosis and Preserved Left Ventricular Ejection Fraction. Circ Cardiovasc Imaging. 2016;9(11):e005022. doi:10.1161/CIRCIMAGING.116.005022
Sadek MM, Yung D, Birnie DH, Beanlands RS, Nery PB. Corticosteroid therapy for cardiac sarcoidosis: a systematic review. Can J Cardiol. 2013;29(9):1034-1041. doi:10.1016/j.cjca.2013.02.004
Betensky BP, Tschabrunn CM, Zado ES, et al. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm. 2012;9(6):884-891. doi:10.1016/j.hrthm.2012.02.010
Pour-Ghaz I, Kayali S, Abutineh I, Patel J, Roman S, Nayyar M, Yedlapati N. Cardiac Sarcoidosis: Pathophysiology, Diagnosis, and Management. Hearts. 2021; 2(2):234-250. https://doi.org/10.3390/hearts2020019
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Anna Gorajek, Małgorzata Kudan, Karolina Mikut
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 297
Number of citations: 0